MIAMI, March 06, 2023 Longeveron Inc. , a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced that the Company will release its. | March 6, 2023
MIAMI, Nov. 07, 2022 Longeveron Inc. , a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced that the Company will release its third. | November 7, 2022